Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Delayed Data
As of Jul 21
 -5.21 / -1.00%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 477.50, with a high estimate of 589.00 and a low estimate of 327.00. The median estimate represents a -7.45% decrease from the last price of 515.92.

Analyst Recommendations

The current consensus among 24 polled investment analysts is to Hold stock in Regeneron Pharmaceuticals. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.26%
Growthannually 13.71%


Growthquarterly 1.72%
Growthannually 13.58%
Key to the earnings and sales forecast charts.